Report questions hasty vax plant shutdowns in India; painkiller abuse deterrent comes under FDA scrutiny;

> India's Union health minister is being accused of ordering the shutdown of three public sector vaccine manufacturing units without a clear analysis. Article

> The FDA questions the deterrent in a painkiller reformulated to curb abuse. Article

> Almac in Ireland has completed a three-story expansion of its pharma services division lab and office areas, adding 30,000 square feet. Article

> Millipore has launched the Milliflex Quantum rapid microbial detection system, which combines membrane filtration and fluorescent staining. Item

> Bioniche Life Sciences has scored $750,000 in funding from the Federal Economic Development Agency for Southern Ontario for development of a pilot-scale fermentation facility. Release

Suggested Articles

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.

AstraZeneca has signed a $750 million deal to produce up to 300 million doses of Oxford University's COVID-19 vaccine by year's end.

Racing with some COVID-19 vaccine heavyweights, Novavax has brought on a partner to manufacture adjuvant for its in-development shot.